Question · asked by 1 review
Pregabalin vs placebo: Dizziness
- Population
- people with drug‐resistant focal epilepsy
- Intervention
- Pregabalin
- Comparison
- placebo
- Outcome
- Dizziness
Pregabalin may leads to higher adverse effect: dizziness compared with placebo (low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Pregabalin vs placebo Adverse effect: dizziness · drug‐resistant focal epilepsy Pregabalin may leads to higher adverse effect: dizziness compared with placebo (low certainty). Pregabalin add‐on for drug‐resistant focal epilepsy (2022) · Cochrane Headline outcomes only | RR 3.15 [2.23, 4.44] | 7 studies · 2193 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Pregabalin add‐on for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Pregabalin vs placebo at end of treatment · patients with fibromyalgia · 1 review
- Pregabalin vs active comparators · people with drug‐resistant focal epilepsy · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.